Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2011-11-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enteral Formula Tolerance in Pediatric Patients
NCT02779335
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
NCT02912065
Enteral Formula Tolerance of Standard Tube Feedings
NCT02312271
Nutritional Tolerance and Safety of a Tube Feeding Formula in Children
NCT05838495
Retrospective Review of Amino Acid Formula Use at a Children's Center
NCT03497091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric developmental disabilities
Children aged 1-13 years old with development disabilities, requiring enteral tube feeding for at least 14 days
enteral formula
Complete feeding of study enteral formula, route and regimen prescribed by the physician
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enteral formula
Complete feeding of study enteral formula, route and regimen prescribed by the physician
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently tolerating enteral feeding
* Requiring nutritional management to meet 50-90th% weight for age on the Kennedy Kreiger Growth Charts
* Requires enteral tube feeding for at least 14 days.
Exclusion Criteria
* Other condition which contraindicates tube feeding
1 Year
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darin Brannan, MD
Role: PRINCIPAL_INVESTIGATOR
The Children's Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Children's Center
Bethany, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11.03.US.HCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.